High blood pressure is the most important preventable risk factor for premature death worldwide, and is associated with 13% of global deaths*. The joint European Society of Hypertension and the European Society of Cardiology Guidelines on arterial hypertension have been regarded as gold standard guidance since they were first introduced in 2003 (when they were amongst the world’s most cited scientific papers). Now new Guidelines are being unveiled at the European Society of Hypertension congress in Milan to coincide with simultaneous publication in the peer-reviewed journals Journal of Hypertension and the European Heart Journal, and Blood Pressure.
These new Guidelines will redefine the approach to diagnosing and treating hypertension. Amongst the recommendations are:
• Revised definitions of hypertension, which will significantly affect the diagnosis of the disease
• Updated recommendations of how hypertension is treated, with a new emphasis on drug selection
• A call for doctors to be more pro-active in initiating treatment, and for patients to be more aware of the endemic problem of high blood pressure
The Guidelines have been developed under the direction of Giuseppe Mancia (co-chair representing the ESH) and Robert Fagard (co-chair representing the ESC). Professor Mancia and Professor Fagard will brief the press on these new guidelines at 12.30 on Saturday 15th June, in the MICO MILANO CONGRESSI NORTH WING – VIA GATTAMELATA – GATE 14 – MILAN. Journalists are welcome to attend.
Please inform Tom Parkhill in advance if you wish to attend.
The full guidelines shall be available from 5 pm (CEST), 14th June, on the following sites: www.jhypertension.com and
See congress website at: http://www.esh2013.org/
*Global health risks: mortality and burden of disease attributable to selected major risks. World Health Organization. 2009 (http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf)
For any media request, please contact:
Email: [email protected]
Telephone: 00 44 131 208 3008
Mobile: 0039 349 238 8191